Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of an inactivated EV71 vaccine in immunocompromised pediatric patients
TCTR20250218016Phase 4Enrolling by invitation
- Sponsor
- Ramathibodi Hospital
- Start
- Feb 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of inactivated EV71 vaccine in enterovirus 71 infection, sponsored by Ramathibodi Hospital. Started Feb 2025; status: enrolling by invitation.
02
Drugs
inactivated EV71 vaccine
03
Conditions
enterovirus 71 infection
Beyond the preview
Go deeper on TCTR20250218016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250218016.